Invests in
Locations:
Min Investment:
$200,000.00Max Investment:
$300,000.00Target Investment:
$250,000.00
Skills
Education
Lists including Will
Investments
Work Experience
2021
Co-Founder & CEO
2021
Engage Bio is developing Tethosomes, the next generation of non-viral DNA medicines. Tethosomes are highly potent, non-immunogenic, redosable, and titratable. At Engage, we're focused on building genetic medicines that scale. www.engagebio.com
2019
Venture Partner
2019
2019 - 2021
Vice President of Development Operations
2019 - 2021
Developing TERT mRNA therapy to extend telomeres and increase the human healthspan.
2015 - 2020
Co-founder and Chief Operating Officer
2015 - 2020
Diagnostic platform for early detection of liver disease. Acquired by diagnostic developer DiscernDx.
2013 - 2015
Senior Program Manager
2015 - 2015
Designed and managed early-phase clinical programs. Participated in business development, including bid defenses and acting as technical sales lead.
Program Manager
2013 - 2015
2012 - 2013
Research Associate
2012 - 2013
2010 - 2010
Economic Analyst Intern
2010 - 2010